SARAH CORREIA: Open Payments
NPI 1801148283 · LAVONIA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 40 payments from 11 companies in 2025. Trend: 2023 $269 · 2024 $411 · 2025 $527
Food & beverage: $517Education: $10
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $147 |
| ABBVIE INC. | 20 | $142 |
| PFIZER INC. | 2 | $40 |
| Amgen Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $33 |
| Biogen, Inc. | 1 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Dexcom, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
Products named: VRAYLAR, Wegovy, NURTEC ODT, OTEZLA, MOUNJARO, Ozempic, SKYCLARYS, FANAPT.
Industry payments across GA — which companies pay providers there.
